Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
Jan K Buitelaar1, J Antoni Ramos-Quiroga2, Miguel Casas2, J J Sandra Kooij3, Asko Niemelä4, Eric Konofal5, Joachim Dejonckheere6, Bradford H Challis7, Rossella Medori81Department of Psychiatry, University Medical Center, St. Radboud and Karakter Child and Adolescent Psychiatry Universit...
Saved in:
Main Authors: | Jan K Buitelaar, J Antoni Ramos-Quiroga, Miguel Casas, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/4949a218c0e4438cbed2e44a68f7c832 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
by: Chou WJ, et al.
Published: (2018) -
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
by: Rajasree Nair, et al.
Published: (2009) -
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
by: Valdizán-Usón JR, et al.
Published: (2013) -
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
by: Masi G, et al.
Published: (2019) -
Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
by: Huss M, et al.
Published: (2016)